Skip to main content

Table 3 Cost (USD at 2018 levels) -per averted DALY by decrease in PrEP prices and % of non-UAI users stopping Condom use on receiving PrEP

From: Cost utility analysis of HIV pre exposure prophylaxis among men who have sex with men in Israel

% non-UAI stopping condom use

Decrease in PrEP prices

BEP price decrease

10%

50%

70%

90%

0%

860,319

479,292

288,779

98,265

87.5%

25%

893,876

500,869

304,366

107,862

88.6%

50%

929,611

523,847

320,964

118,082

89.6%

75%

967,744

548,366

338,677

128,987

90.7%

  1. Notes: Assumes 80% PrEP take up by high-risk MSM,
  2. 25% PrEP take up by low-risk MSM
  3. PrEP efficacy of 86.0% (References (4, 5)
  4. Based on MOH payment schedule to HMOs for HIV/AIDS patients
  5. BEP Break Even Point (price decrease) for cost-effectiveness